Sermorelin: No Sizable Gains Over Somatropin New Drugs and Disease Management 23 November 2012 Pages: 1 - 4
Drug Therapy Limited in Patients with Huntington’s Disease New Drugs and Disease Management 23 November 2012 Pages: 5 - 7
What can be Done to Stop the Global Threat of Tuberculosis? New Drugs and Disease Management 23 November 2012 Pages: 8 - 12
Moxonidine a Better Tolerated Centrally Acting Antihypertensive? Drug Reactions and Interactions 23 November 2012 Pages: 12 - 14
Moxonidine Trial in CHF Halted because of Safety Concerns Drug Reactions and Interactions 23 November 2012 Pages: 14 - 14
Prevention and Disease Management are Worth the Investment Drug Economics and Quality of Life 23 November 2012 Pages: 14 - 16
